Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Tag: Epicutaneous Immunotherapy (EPIT)

Non-Profit Institute to Review Benefits of Commercial, Private Practice Immunotherapies for...

DBV Applies for FDA License to Sell Viaskin Peanut Patch Therapy

Viaskin Peanut Completes Phase III Part A Study of Toddlers With...

Study: Immunotherapy Trials for Food Allergy Hold Strong Appeal for Parents

Positive Safety Results Reported for Viaskin Peanut Phase III Trial

Peanut Patch Phase III Enrollment Ends, Results Expected Toward End of...

Adult Peanut Allergy: Therapy Cleared to Begin Phase IIa Trials

Study: Peanut Immunotherapy Significantly Reduces Risks Due to Cross-Contact in Common...

Viaskin Patch Delivers Long-Lasting Peanut Desensitization After Phase IIb Trial

Study: EPIT (Skin Patch) Therapy Provides Sustained Protection Against Anaphylaxis

Follow Us

Your School On Our Map

Put Your School on the Map